CSTL Castle Biosciences Inc.
Health Care, filed as Castle Biosciences Inc (COMMON STOCK), Equity Among managers we track Quote on Google Finance, opens in a new tab
No current holdings among managers we track for this security. See ownership history or the ownership grid, activity, or search.
Insider trades
Open-market buys and sales by CSTL's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $3M sold by 4 insiders outside a trading plan
- $16.7M sold by 4 insiders under 10b5-1 plans
-
Derek J Maetzold Pres. & Chief Exec. OfficerPlanned sale$523K 14,496 shares at $36.10Traded Nov 2 Filed Nov 4
-
Tobin W Juvenal Chief Commercial OfficerPlanned sale$240K 6,578 shares at $36.42 15% of stakeTraded Oct 28 Filed Oct 30
-
Tobin W Juvenal Chief Commercial OfficerPlanned sale$109K 3,288 shares at $33.08 6.7% of stakeTraded Oct 26 Filed Oct 28
-
Derek J Maetzold Pres. & Chief Exec. OfficerPlanned sale$463K 14,496 shares at $31.91Traded Oct 19 Filed Oct 21
-
Tobin W Juvenal Chief Commercial OfficerPlanned sale$111K 3,288 shares at $33.64 6.3% of stakeTraded Oct 12 Filed Oct 14
-
Derek J Maetzold Pres. & Chief Exec. OfficerPlanned sale$516K 14,496 shares at $35.57Traded Oct 5 Filed Oct 7
-
Kristen M Oelschlager COOPlanned sale$149K 4,153 shares at $35.95 24% of stakeTraded Oct 1 Filed Oct 5
-
Tobin W Juvenal Chief Commercial OfficerPlanned sale$232K 6,577 shares at $35.29 11% of stakeTraded Sep 29–30 Filed Oct 1
-
Derek J Maetzold Pres. & Chief Exec. OfficerPlanned sale$512K 14,496 shares at $35.33Traded Sep 21 Filed Sep 23
-
Tobin W Juvenal Chief Commercial OfficerPlanned sale$223K 6,600 shares at $33.73 10% of stakeTraded Sep 14–15 Filed Sep 16
-
Derek J Maetzold Pres. & Chief Exec. OfficerPlanned sale$465K 14,518 shares at $32.02Traded Sep 11 Filed Sep 15
-
Kristen M Oelschlager COOPlanned sale$139K 4,152 shares at $33.39 24% of stakeTraded Sep 1 Filed Sep 3
-
Tobin W Juvenal Chief Commercial OfficerPlanned sale$57K 1,730 shares at $32.81 2.6% of stakeTraded Aug 31 Filed Sep 2
-
Derek J Maetzold Pres. & Chief Exec. OfficerPlanned sale$616K 18,560 shares at $33.20Traded Aug 28 Filed Sep 1
-
Tobin W Juvenal Chief Commercial OfficerPlanned sale$317K 9,050 shares at $35.04 12% of stakeTraded Aug 25 Filed Aug 27
Also filed in the last 12 months, not counted as buying or selling: 50 option exercises, 16 share withholdings for taxes, and 4 stock grants.
SEC filings
Recent issuer filings from EDGAR, 5 shown.
Financials
US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.
Income statement
Balance sheet
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Total current assets | $295.64M | $360.15M | $361.1M |
| Total non-current assets * | $157.7M | $171.08M | $217.46M |
| Total assets | $453.34M | $531.24M | $578.56M |
| Total current liabilities | $47.67M | $49.39M | $68.68M |
| Total non-current liabilities * | $14.4M | $26.01M | $39.01M |
| Total equity | $391.27M | $455.84M | $470.87M |
Ownership over time
13Fs that reported it each quarter. Click a bar for that quarter’s holders.
Further reading
As an Amazon Associate, FollowTheFilings earns from qualifying purchases.
- How to Read a Financial Report (Tracy & Tracy) View on Amazon
- Financial Statements QuickStudy Laminated Guide View on Amazon